Kengo Takeuchi

RET, ROS1 and ALK fusions in lung cancer

Kengo Takeuchi, Manabu Soda, Yuki Togashi et al. · Nature Medicine · 2012 · 1.3K citations

Oncology, Medicine, Cancer Genetics +4

EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors

Young Lim Choi, Manabu Soda, Yoshihiro Yamashita et al. · New England Journal of Medicine · 2010 · 1.2K citations · Full text

Pathology, Fusion-type Tyrosine Kinase, Cancer Biology +16

Integrated molecular analysis of adult T cell leukemia/lymphoma

Keisuke Kataoka, Yasunobu Nagata, Akira Kitanaka et al. · Nature Genetics · 2015 · 825 citations

Lymphoid Neoplasia, Medicine, Mixed-phenotype Acute Leukemia +7

KIF5B-ALK, a Novel Fusion Oncokinase Identified by an Immunohistochemistry-based Diagnostic System for ALK-positive Lung Cancer

Kengo Takeuchi, Young Lim Choi, Yuki Togashi et al. · Clinical Cancer Research · 2009 · 711 citations

Aberrant PD-L1 expression through 3′-UTR disruption in multiple cancers

Keisuke Kataoka, Yuichi Shiraishi, Yohei Takeda et al. · Nature · 2016 · 627 citations

Aberrant Pd-l1 Expression, Cancer Cell Biology, Pathology +5